This study is looking at women over 55 with overactive bladder (OAB) who are already scheduled to receive Onabotulinum toxin type A injections. Researchers want to understand how the genitourinary (urinary and genital) microbiome (the community of tiny organisms) changes before and after these injections. They will collect urine samples to compare how the microbiome looks before treatment and four weeks after. The main goal is to see if they can successfully recruit participants and work with experts to collect and analyze these samples. This study is observational, meaning you will receive your standard treatment, and researchers will collect information about it. The study aims to enroll 40 participants.

Study design

This is a single-site observational study planning to enroll 40 women. It is not a randomized study, meaning there is no comparison group receiving a different treatment.

What's involved

You will have urine samples collected at the beginning of the study and again four weeks after your Onabotulinum toxin type A injection. You will also complete one self-collection and one clinic-collection at each time point.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for approximately one month after the Onabotulinum toxin type A injection.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.